This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Product Information

LISDEXAMFETAMINE 40 MG TB CHEW is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $4.1782 per EA under NDC 72205013591. Its NADAC has been published 107 times since Nov 6, 2024.

FDA first approved this application on Feb 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 40 MG TB CHEW

Lisdexamfetamine dimesylate
$4.1782per EA
DEA Schedule CII

Strength

40 mg/1

NDC

72205013591

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218306

FDA Approved

2/2/2024

TE Code

AB

On Market Since

2/2/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has been published 107 times since Nov 6, 2024, and over the history we have for it it has declined 47.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.1782 per EA
All-time high$8.6514 (May 14, 2025)
All-time low$3.7243 (Aug 19, 2026)
52-week high$6.3117
52-week low$3.7243
Median price$6.3117
Average price$6.2721
Largest weekly change-10.8% (Mar 18, 2026)
Weeks tracked107
Tracking sinceNov 6, 2024

Price History

1W

+0.1%

1M

+5.0%

3M

+12.2%

6M

-3.5%

1Y

-33.2%

3Y

N/A

5Y

N/A

All

-47.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 40 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG TB CHEW, manufactured by Novadoz Pharmaceuticals LLC, is $4.1782 per EA (NDC 72205013591), effective Nov 18, 2026.

How has the price of LISDEXAMFETAMINE 40 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has declined 47.9%. It has been tracked across 107 weekly CMS publications since Nov 6, 2024.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG TB CHEW?

Since Nov 6, 2024, the NADAC for LISDEXAMFETAMINE 40 MG TB CHEW has ranged from a low of $3.7243 (Aug 19, 2026) to a high of $8.6514 (May 14, 2025), with a median of $6.3117 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG TB CHEW?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 40 MG TB CHEW in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 40 MG TB CHEW?

LISDEXAMFETAMINE 40 MG TB CHEW (NDC 72205013591) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 40 MG TB CHEW in shortage?

Yes — NDC 72205013591 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).